Scientists have made a "promising" advance towards developing a universal coronaviruses vaccine.

According to researchers at the Francis Crick Institute in London, there is a good target for a pan-coronaviruses jab that could offer protection against all the Covid-19 variant.

They said that developing a vaccine that protects against a number of different coronaviruses is a huge challenge because they have many key differences. It is possible for people to catch a cold multiple times, and it is also possible for them to be exposed to different versions of sars-coV-2.

Scientists said a universal coronaviruses vaccine would need to stop the coronaviruses from entering host cells and replicating.

In the new study, the researchers looked at the effect of antibodies on other coronaviruses. The researchers found that after the mice werevaccinated with the sars-coV-2 S2 vaccine, they were able to create anti- coronaviruses.

The first wave, Alpha, Delta, the original Omicron and two bat coronaviruses were also included. The findings have been published.

Kevin Ng of the Francis Crick Institute said that the S2 area of the spike is a promising target for a potential pan-coronaviruses vaccine. The vaccine should be more robust because it is less susceptible to the effects of Mutations.

The researchers said that the S2 area had been overlooked as a potential basis for vaccine.

The expectation for a vaccine that targets the S2 area is that it will offer some protection against all current and future coronaviruses.

The vaccine that targets the more variable S1 area is less able to target other variant or a broad range of coronaviruses.

There is still a lot of research to be done as we look for the most appropriate way to design and test a vaccine.

The researchers are studying the potential of a pan-coronaviruses that targets the S2 area of the spikeProtein and how it could be integrated with currently licensed vaccines

Our daily newsletter is sent out every weekday at 7am.

While a potential S2 vaccine would not stop people being infections, the idea is that it wouldprime their immune system to fight future coronaviruses.

It would hopefully give them enough protection to survive an initial attack on that particular virus.

ProfPenny Ward, a visiting professor in pharmaceutical medicine at King's College London who was not involved in the study, said a universal coronaviruses vaccine could solve the problem of endless new waves of disease caused by variant with reduced vaccine sensitivity.